A
LTHOllGH HEPATOBILIARY DlSEASE is a well recognized complication of both idmpathic ulcerative colitis and Crohn's disease, imrortant d ifferences exist in the mcidence and rype of liver d isease associated with these two diS<lt· ders ( I-3) . In rarticular. biochemical cndence of ch ron ic liver d isease is found m 8 to 50% of ulcerative colitis patients (4· 7). while only 4''., of Croh n's diM?a'-C patients have persistent elevations of their serum liver enzyme levels ( Ul Moreover, in ulcerative colitis, primary sclerosing cholangitis is the most com· mon associated hepatic disorder ( 2,8-LO), while in Crohn's disease, hepatic stcat· osis and gra n ulomas are more often found ( I I ). These findings suggest that the hepatobiliary com pl ications of ulcer· ative colitis and Croh n's disease may be caused hy different parhogeneuc mechanisms.
Recen tly. 11 was reported that paucnt, with ulcerative colitis and ch ron ic liver disease have an impaired ability to clear immune complex-like material from the systemic circulation ( 12 ) . This d efect did nor exist in patients with ulcerative colitis alone or patie nts with clearly defined liver disease of other etiologies. On the bas is of these and other investigators' findings (13.14) , it was proposed that immune complexes could play an important role in the pathogenesis of the liver disease associated ulcerative colitis. The present study aimed to dete rmine if the same clearance defect exists in Crohn's disease patie nts with o r without associated liver d iscasc.
MATERIALS AN D METHODS
Study po pula tio n s : Four groups of individuals were studied: 12 healthy volunteers; nine patients with Crohn's disease only. ie, normal liver enzyme levels on two separate occasions at least o ne month apart; nine patients with Crohn's disease and persistent elevations of liver enzyme levefs (mninotransferases 2 or more times normal or a lkaline phosphatase and gamma glutamyltransfcrasc I . 5 or more times normal) o n two separate occasio.,s at least one mo nth apart; and 12 patients with various other fr1rm s of liver disease including alcoholic liver disease (n = 6). chronic vira l hepatitis (n = 2). commo n bile duct stricture (n = I). choledochal and intrahepatic lithiasis (n = I). hemochromatosis (n -I) and drug-induced cholesrntic jaundice (n = I). Crohn's disense pmienrs wirh or without liver enzyme a bnormalities were identified by re trospective ch art review.
A ca reful hi story, physical exami n ation and the ap propriate laboratory tests were perfo rmed on ;ill patie n ts with Crohn's and liver di sc;isc to exclude readily idcntifiahlc causes ofliver disease. including alcohol. drugs. viral infection and mernbol ic disorders. Bec;i use live r enzyme levels were only mildly elevated, invasive procedu res such as percutaneous liver biopsy or endoscopic retrogrndc cholangiography were not performed and thus the exact na ture of the liver disease in these patients wa s unknown .
Three of nine Crohn's and liver disease patients had complaints consistent with cxtrainccstinal C ro hn's Jiseasc !arth ritis in a ll three), as compared to (our of nine patients with Crohn's dis- Written, informed co nsen t was obtained from all study participants. The study w;is approved by the Univl'rsity of Calgary and Foo thill s Hospita l Ethics Co mmittee a nd Radi nrio n Safoty Committee at the University o f C:i lgn ry. C li ni cal a n d la b o r ato r y investiga• tion s : All p:irticir:inrs h;id blood drawn for thl' following laboratory tests: sc rum asparmte aminotransferase; ;il:,nine aminotransferase; alk:i linc phosphmase; and gamma glutamvltransfcrn~e In addition. sera were tested for lgA. lgG and lgM level~ as well a~ ~crum C 1 :ind C 4 levels. The~e in vestigatio ns were performed hy hospirnl clinical laboratories usi ng srnnd;ird lahora to ry techniq ues. Sera were screened for immune complex-like ;icri viry hy solid ph;isc enzymc-lmked 1m munonss.iys for both lgG and lgM complexes ! 15) I mmu n e comple x c learance by the r etic ul oend oth c lial system: Erythrocyte cleara nce studies were carried out on all Rh(D) positive patients ;is previously described ( 16, 17) . In brief. autologous e rythrocytes were isolated from whole blood. washed three times in ice cold physiologic sa line and resuspended ro:, concentration adjusted photomcrrica lly to 6.6 x I 0 8 cdls/m L. The cell s were la belled with steril e ; I C r (Na 2 ; tCrO 10 µCi/ml, Amersham -Se;irle Corporation. Arlington Heights, II), waslwd fou r times in physiologic sa line. then resuspended to a concentration of 3. following which the lgG sensitized ' 1 Crlabelled e ryth rocytes we re w,ished twice and resuspended in p hysio logic saline An ;iliquot of cells (contnin ing app roximately 250,00() cou n ts/min) w;is then injected through an anrecubical vein. rind eryrhrocyrc surviv;il rnlcul;ired from the radioactivity m blond samples obtained at 5. 10. 30,60.90and 120mins(AUC Trapezoid a l Rult' . Ti 59), as recommended hy tht' In terna tional Committee for Swnd;irdiw1ic1n in H;icmmology 11 H). In no rnsc was n clearnncc study followed hy any un1nward effect Defi nitions and statistical tec hniques:
The hall-life of tlw radiochromnted cells is the time :it which 50''., of thl' labelled cells lrns bt'cn removed from the circulation A Student's 1 test and Fisher's ex:1n test were used for determining differences hct ween grnu ps of p:111ents :in d controls. Onlv P vnlues less th;in 0.05 were con-,idered significant RESULTS Table I provides the resu lrsof :,ge. sex .ind liver enzyme tests for the fou r study groups. Liver disease patients hnd more severe liver disease than Crohn's and liwr disease patien ts ;is manifest hy the Table 2 . Compared to healthy voluntecrs. mc::in scrum lgA. lgG and lgM levels were normal in Crohn's disease and Cmhn's and liver disease pmients hut lgA and lgG levels were signific::in rly elevated (P < 0.01 and P < 0.05. respectively) in liver disease controls. Mean serum C 1 and C 4 levels were similar in all four study groups. Imm une complex-like ac- tivity was higher in !iv e r disease patients when compared to Crohn's disease (P < 0.05) and Crohn' sand liver disease patients (P < 0.05) but not statistically d iffcrcnt from hc::ilthy vol untcers(P = 0.06).
The results of lgG-tagged erythrocyte clearance studies arcs hown in Figure I . All patients had norm al clearance curves when compared to he al thy controls. . . The reticulnendothelial system's ability to clear immune complex-like mate rial from the sys temic nn: ulatton has been used previously 10 prm 1de msight into the pathogenesis of diseases t h;n arc potentially 1mmunologically mediated ( 19) Abnormal clearance functton has now been documentL'd 111 pauems \\'ith systemic lupus crvthcmmosus (ZO). mixed cryoglobul111cm1a ( 19) . SJ01-:ren s syn drome (21 ) . mixl·d connecuve ussut· disme (22) . primary biliary cirrhosis ( 16) . primary scleros111g cholangit1s ( Z ~) and ulcerative colit1s ( I Z) l n some nf thesl' disorders impaired clearance suggests disea:.c cxtendmg beyond the primary target tissue Thus, in mixed cry()globulmemia prolonged clearance umcs 111d1-cate the presence of etlex1st111g renal involvement ( 19) : 111 S1ogren'ssyndromc, disease beyond tht· salivary glands (21 ) . and hepatic involvcnwnt m ulcL·rative colins ( 12) The rcsulb ot the prl'scnt study suggest rhat immune complex-like clearance funrnnn bv the rL'llCUioL·nJ~)-Vol I No l October l9H7 thehal system 1s enher normal or mmimally prolonged in Cmhn's disease patients whether their disease 1s confinL·d tn the bowel or associated with cxrr.untt'sllnal marnfostauons.
A direct comparison bL•twecn the results ot the present study and those nf tl1L' earlier ulcerau,·e colitis studv ( 12) c;mnot he m;ide for a number of reasons. First. as reflected 111 the more rapid clearance nmes for controls, a higher concentration of lgG ant1ht1dies per red blood cell was used 111 the pre-.cnt study. The higher antibtldy concentration was employed in order to 111crL·asc the scns1-t1 ,. i ty of the assay ( 17) Secondly. the liwr enzyme ahnormaliucs 111 Crohn's and liver disease patients were Mgn1ficandy lmver 111 the present studv than 111 those ,, llh ulcerative colitis and li\'Cr disease. Indeed. the abnormaliucs in the former group were so slight th.u mvast\'L' lll\'L' Suganons, which might have bcncr detined their cause, were not pertormt·d Nonetheless, the cmymc abnormal1ucs oh-.erved tn Crohn's and liwr disease patients were pcrs1stt.·nt and noc rcndily atrrihutabk· m mhcr causes F111allv. a larger percentage of Crohn's and liVL'r d isease pattt·nts ( 'i6''.,l th.in ulcerauve colitis and liver disease paucnts ( ZO"i,l WL're tak111g corncostem1ds for c11nrrol of their bowel disease This may be rcle-,ant 111 that. m t.',pcnmcntal a111mab. cort1coster01ds ha\'c been shown to alter immune complex clearance mnes by the rcuculoendothelial svstL'm ( 17 .24) It shnuld be noted . howe\'l'r, that no difference w,1s found m clearance times het\\'el.'11 Crnhn's d1.,cast• patlL'l1ls ren•1v-111g corncosteroids \'L'rsu ... thosL' that \\'ere not
The mtcrpretallon and s1g111f1cancc ot serum immune complex-like acuvity 111 panents with 1rnmunolog1cally nwd1atcd disease rema111:. n controversial 1ssL1l' (25) (26) (27) (28) (29) (30) In the present study. rnntrary to previous reports ( 14.> 1-14 ) . ncllher Crohn\; and liver disease panents nor Crohn'sdi:;casc panents without liver d1s-ea'>e had elevated levels of immune complex-like act1v1ty 111 their scrum The reason for the di:;(rt.·pancy between the present authors' results and others' 1s unclear The nonspeciiil nature of the ass,1ys presently employed for the detection ot scrum immune cnmpll''-t's would Fe-receptor clearances ,n Crohn's appe.ir to be a maJor conmhut1ng factor (28.29)
In conclusion. this study shows that the defect 111 the rl'ticuloendtlthclial sys· tem's abdny to clear spec1f1c 1111mum· complex-like matL'nal from tl1L' systemic circulation of patients with ulcernrive colitis and liver d1sc,1sc 1s f1l)t present in Crohn\ d1seasl' pat1e11ts w1tl1 mild but persistent liver t'n:vmc ahnormal1t1L'S ACKNOWLEDGEMENTS: Thl' ;n11hor, .11:kmm le<lgl' dw support 111 th<· MSI h,un<la ll(lll ul Allwna ;111J tht· :lSSIM:llll'C of Ms n Rish,,p for lwr rn1mp1 and ilC<"llr.m· typmg ,,t 1he manu,cnp1
